The goal of this clinical trial is to analyse the prevalence of new or uncontrolled arterial hypertension (AHT) after hospital discharge of medical in-patients with elevated blood pressure (BP) values during hospitalisation. The main questions it aims to answer are: * Do elevated BP values during hospitalisation correspond to new or uncontrolled AHT after hospital discharge? * Is it safe to postpone adaption of antihypertensive treatment until after proper evaluation of AHT after hospital discharge? Participants will either be treated according to their physicians' decision or antihypertensive treatment adaptions will be postponed until after hospital discharge.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Enrollment
800
Hypertensive blood pressure values in medical in-patients will not be treated during hospitalisation until confirmed by ABPM 4 weeks after hospital discharge
University Hospital Basel
Basel, Switzerland
RECRUITINGPrevalence of persisting new or uncontrolled arterial hypertension
Elevated blood pressure values in ambulatory blood pressure monitoring
Time frame: 4 weeks after hospital discharge
Prevalence of a combined hypertensive complication endpoint
Consisting of intracerebral bleeding, ischemic stroke, myocardial infarction, cardiovascular death or cardiovascular re-hospitalization
Time frame: Until 4 weeks after hospital discharge
Prevalence of a combined hypotensive complication endpoint
Consisting of falls, acute kidney injury, electrolyte disturbances, re-hospitalizations due to hypotension, or BP values on ABPM below the lower treatment limit
Time frame: Until 4 weeks after hospital discharge
Clinic blood pressure measurement in mmHg
Documented in the patient documentation
Time frame: At baseline
Research blood pressure measurement in mmHg
Standardized blood pressure measurement taken by research staff
Time frame: At baseline
Prevalence of previously unknown arterial hypertension
No previously documented diagnosis of arterial hypertension and no antihypertensive treatment
Time frame: At baseline
Prevalence of female gender
As reported by participant
Time frame: At baseline
Prevalence of re-hospitalization for any cause
According to hospital documentation and patient interrogation
Time frame: Until 4 weeks after hospital discharge
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.